SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease
2021 · Neurotherapeutics · 16 citations
https://doi.org/10.1007/s13311-021-01143-1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Run Rong Kuang is an academic researcher.
Click to start Chat